Related Experiment Video
Updated: Jun 28, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy
Durk Fekkes1, Arthur R Van Gool, Marjolein Bannink
1Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands. d.fekkes@erasmusmc.nl
Abstract:
Both increased and decreased nitric oxide (NO) synthesis have been reported in patients treated with interferon-alpha (IFN-alpha). Animal studies showed that IFN-alpha administration results in increased levels of biogenic amines, subsequent activation of monoamine oxidases (MAOs), and finally in a change in NO production due to the H(2)O(2) generated by MAOs. We examined the potential relationship between NO production in plasma and MAO-B activity in platelets of 43 cancer patients during 8 weeks of treatment with IFN-alpha. NO synthesis was quantitated by measuring both the ratio of citrulline and arginine (CIT/ARG-ratio) and total nitrite/nitrate (NOx) levels. Compared to baseline, MAO activity and NOx increased, while the CIT/ARG-ratio decreased. No associations were found between NOx, MAO and CIT/ARG-ratio. Only few associations were observed between changes in the biochemical parameters and changes in psychopathology induced by IFN-alpha, of which the association between changes in CIT and lassitude was the most consistent. The results suggest that peripheral NO production and MAO activity are unrelated to each other, and that peripheral changes in these biochemical parameters induced by IFN-alpha are unlikely to contribute to definite psychiatric disturbance.
Insights
Interferon-alpha (IFN-alpha) treatment alters nitric oxide (NO) and monoamine oxidase (MAO) levels in cancer patients. Peripheral NO production and MAO activity appear unrelated and unlikely to cause psychiatric side effects.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Interferon-alpha (IFN-alpha) treatment in cancer patients has conflicting reports on nitric oxide (NO) synthesis.
- Animal studies suggest IFN-alpha influences biogenic amines, monoamine oxidases (MAOs), and subsequently NO production via hydrogen peroxide (H2O2).
Purpose of the Study:
- To investigate the relationship between plasma NO production and platelet MAO-B activity in cancer patients receiving IFN-alpha.
- To assess biochemical changes during IFN-alpha therapy and their potential link to psychopathology.
Main Methods:
- Quantified NO synthesis by measuring citrulline/arginine ratio (CIT/ARG-ratio) and total nitrite/nitrate (NOx) levels.
- Assessed MAO-B activity in platelets of 43 cancer patients over an 8-week IFN-alpha treatment period.
Main Results:
- MAO activity and NOx levels increased significantly compared to baseline.
- The CIT/ARG-ratio decreased during IFN-alpha treatment.
- No significant associations were found between NOx, MAO activity, and the CIT/ARG-ratio.
- Few links between biochemical changes and psychopathology were observed, with changes in citrulline (CIT) and lassitude being the most consistent.
Conclusions:
- Peripheral NO production and MAO activity are not directly related in patients treated with IFN-alpha.
- Observed peripheral biochemical changes are unlikely to be the primary cause of significant psychiatric disturbances during IFN-alpha therapy.
Related Concept Videos
Nitric Oxide Signaling Pathway
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibitors of Viral Protein Synthesis
